<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
FIRST HORIZON PHARMACEUTICAL CORPORATION
-------------------
(Exact name of Registrant as Specified in its Charter)
<TABLE>
<CAPTION>
<S> <C>
DELAWARE 58-2004779
- ----------------------------------------------------------------- ------------------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification no.)
660 HEMBREE PARKWAY, SUITE 106, ROSWELL, GEORGIA 30076
- ----------------------------------------------------------------- ------------------------------------------------
(Address of principal executive offices) (zip code)
</TABLE>
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. [ ]
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box. [X]
Securities Act registration statement file number to which this form
relates: 333-30764
---------------------
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
None
- ------------------------------------ -----------------------------------
- ------------------------------------ -----------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, PAR VALUE $.001 PER SHARE
-------------------------------------------------
(Title of Class)
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
The description of the Common Stock, par value $.001 per share, of
First Horizon Pharmaceutical Corporation (the "Registrant") set forth under the
caption "Description of Capital Stock" in the Prospectus filed by the
Registrant with the Securities and Exchange Commission on February 18, 2000 as
part of its Registration Statement on Form S-1 (Registration No. 333-30764)
(the "Form S-1"), as amended from time to time, is hereby incorporated by
reference in answer to this item.
ITEM 2. EXHIBITS.
The following exhibits which have been filed as exhibits in the Form
S-1 are hereby incorporated by reference as exhibits in answer to this item.
1. Restated Certificate of Incorporation of the Registrant (filed as
Exhibit 3.1 of the Form S-1).
2. Restated By-laws of the Registrant (filed as Exhibit 3.2 of the
Form S-1).
3. Form of Stock Certificate (filed as Exhibit 4 of the Form S-1).
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
FIRST HORIZON PHARMACEUTICAL
CORPORATION
Date: March 27, 2000 By: /s/ R. Brent Dixon
------------------------------
R. Brent Dixon
President
